Pfizer
FDA Expands Approval of Pfizer's Lorbrena to First-Line ALK-Positive NSCLC; Approves Roche CDx
Based on full approval from the FDA based on the Phase III CROWN trial, Pfizer can now market the drug as a front-line option for ALK-positive NSCLC patients.
Opko Health Q3 Revenues Up 87 Percent
The firm's subsidiary BioReference Laboratories performed 3.5 million COVID-19 PCR tests and 300,000 serology tests during the quarter.
Roche EGFR Mutation Test Approved by FDA as Companion Diagnostic for NSCLC
Roche's real-time PCR test detects defined mutations of the epidermal growth factor receptor gene in DNA from non-small cell lung cancer patients.
In Brief This Week: Exact Sciences, Danaher, Yourgene Health
News items for the in vitro diagnostics industry for the week of Oct. 5, 2020
PerkinElmer is providing its recently FDA-approved test for the program, which has identified one baby, so far, as positive for DMD.
Apr 30, 2019
Exact Sciences Q1 Revenues Up 79 Percent
Oct 30, 2018
Exact Sciences Q3 Revenues Up 63 Percent
Oct 12, 2018
AmoyDx Lung Cancer CDx Approved in South Korea
Aug 22, 2018